Online Pet Medications & Pet Supplies

METACAM CHEW TABS DOG 2.5MG X84

Category: M

Select Option
METACAM CHEW TABS DOG 2.5MG X84 - £ 98.32
QTY:
Product REF: BMMET24
METACAM CHEW TABS DOG 84X1MG - £ 46.44
QTY:
Product REF: BMMET23
METACAM CHEW TABS DOG 84X1MG - £ 46.44
QTY:
Product REF: BMMET23

Total Price: £0.00


Vat Rate: 20%

Prescription Required



For alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.

Our Standard Delivery - £6.75

Royal Mail Tracked 24 (Signed For)

  • Next business day service
  • Compensation cover up to £100
  • Signature on delivery

 

Any orders placed after close of business on Thursday will not be delivered until Tuesday

 

 

 

Our Express Delivery - £10.45

Royal Mail Special Delivery Guaranteed by 1pm

  • Next business day service
  • Insured up to £500
  • Signature on delivery

 

Please note that all chilled deliveries must be sent on an Express service.

Chilled orders placed after close of business on Wednesday will not be despatched until Monday

You must be logged in to write review
Category POM-V
Temperature Ambient
MA/VM/EU No: 04491/5020
Species
  • dogs
VMD Link https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2177183.PDF
NOAH Link
Dosage Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day, which can be given orally or alternatively using Metacam 5 mg/ml solution for injection for dogs and cats. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight. Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog, or a 25 kg body weight dog respectively. Each chewable tablet can be halved for accurate dosing according to the individual body weight of the dog. Metacam chewable tablets can be administered with or without food, are flavoured and are taken by most dogs voluntarily. Dose scheme for the maintenance dose: Body weight (kg) Number of Chewable Tablets mg/kg 1 mg 2.5 mg 4.0 - 7.0
Withdrawals Do not use in pregnant or lactating animals. Do not use in dogs suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in dogs less than 6 weeks of age or less than 4 kg body weight. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Special precautions for use in animals Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity. This product for dogs should not be used in cats as it is not suitable for use in this species. In cats, Metacam 0.5 mg/ml oral suspension for cats should be used. Typical adverse drug reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have very rarely been reported from post-marketing safety experience. Very rare cases of haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported from post-marketing safety experience. These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought. The frequency of adverse reactions is defined using the following convention: • very common (more than 1 in 10 animals treated displaying adverse reactions) • common (more than 1 but less than 10 animals in 100 animals treated) • uncommon (more than 1 but less than 10 animals in 1,000 animals treated) • rare (more than 1 but less than 10 animals in 10,000 animals treated) • very rare (less than 1 animal in 10,000 animals treated, including isolated reports). The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Metacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids. Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacological properties of the products used previously. In case of overdose, symptomatic treatment should be initiated. Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.